LUND, Sweden, June 1, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that Eli Lilly and Company ("Lilly") has exercised its option to include amylin receptor agonists (amylin) in the collaboration and license agreement entered in June 2025. The decision extends Lilly's...
Hence then, the article about camurus announces expansion of lilly collaboration was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Camurus announces expansion of Lilly collaboration )
Also on site :
- Southeast Asia shouldn’t copy the U.S. healthcare model, says Walgreens Boots Alliance’s APAC head: ‘It saves your life, but it’s not very healthy’
- Russian investors win battle over frozen assets
- In 1974, George Harrison Named the One Beatle He’d Happily Form Another Band With — and It Wasn’t Paul McCartney